May 4, 2026 · Form 4 insider transaction
Eastling Thomas Wilson bought 47,530 shares of Gyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
This option is fully vested.